Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.12 CAD
Change Today 0.00 / 0.00%
Volume 0.0
NXG On Other Exchanges
As of 12:07 PM 03/24/15 All times are local (Market data is delayed by at least 15 minutes).

nexgenrx inc (NXG) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/17/14 - C$0.23
52 Week Low
08/14/14 - C$0.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEXGENRX INC (NXG)

Related News

No related news articles were found.

nexgenrx inc (NXG) Related Businessweek News

No Related Businessweek News Found

nexgenrx inc (NXG) Details

NexgenRx Inc. provides health claims adjudication and related services in Canada. The company administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers. It offers prescription drug claims adjudication; dental claims adjudication; and claims adjudication for extended health benefits, including paramedical services comprising chiropractors, podiatrists, and massage therapists, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; emergency out of province/country travel benefits; collection and payment of premiums for life and LTD coverage; retrospective and prospective claims data analysis; Web claims submission services; and medical concierge services. It offers its benefits to plan sponsors, brokers, consultants, and third party administrators. The company was founded in 2003 and is headquartered in Toronto, Canada.

Founded in 2003

nexgenrx inc (NXG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$165.0K
Interim Chief Financial Officer
Total Annual Compensation: C$90.0K
Compensation as of Fiscal Year 2013.

nexgenrx inc (NXG) Key Developments

NexgenRx, Inc. Announces Earnings Results for the Year Ended December 31, 2014

NexgenRx, Inc. announced earnings results for the year ended December 31, 2014. Revenue for the year ended December 31, 2014 was $4,216,404. The net loss for the year was $477,616 resulting in negative $0.01 per common share.

NexgenRx, Inc. expected to report Fiscal Year 2014 results on March 31, 2015. This event was calculated by Capital IQ (Created on March 25, 2015).

NexgenRx, Inc. expected to report Fiscal Year 2014 results on March 31, 2015. This event was calculated by Capital IQ (Created on March 25, 2015).

NexgenRx, Inc. Announces Retirement of John Hawkrigg as Director

NexgenRx, Inc. announced the retirement of John Hawkrigg from his position as a director of the corporation. Mr. Hawkrigg has served as a director of the company for the past nine years.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NXG:CN C$0.12 CAD 0.00

NXG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NXG.
View Industry Companies

Industry Analysis


Industry Average

Valuation NXG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEXGENRX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at